Caicun Zhou

机构：Shanghai Pulmonary Hospital, Shanghai East Hospital · ORCID：0000-0002-7095-0381

发表论文 72 篇 · 总被引 2523 次 · h-index 23

代表论文

• Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy (2021 · Acta Pharmaceutica Sinica B · 被引 329)
• FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III (2021 · Journal for ImmunoTherapy of Cancer · 被引 29)
• LBA93 EXTENTORCH: A randomized, phase III trial of toripalimab versus placebo, in combination with chemotherapy as a first-line therapy for patients with extensive stage small cell lung cancer (ES-SCLC) (2023 · Annals of Oncology · 被引 27)
• Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer (2021 · Journal for ImmunoTherapy of Cancer · 被引 25)
• Mechanisms of Progression and Heterogeneity in Multiple Nodules of Lung Adenocarcinoma (2021 · Small Methods · 被引 18)
• Single-Cell Profiling of Tumor-Associated Neutrophils in Advanced Non-Small Cell Lung Cancer (2023 · Lung Cancer Targets and Therapy · 被引 10)